Abstract
Accurate mathematical models are needed to simulate and validate dual-hormone control algorithms for artificial pancreas systems. Glucagon receptors are a key component for glucagon to have effect on glucose. However, they are not usually taken into consideration in the development of models for type 1 diabetes (T1D). In previous work, a model proposal integrating glucagon receptor dynamics into endogenous glucose production (EGP) was successfully validated under single glucagon boluses. In this work, this model is further validated using a dataset of clinical data where two glucagon doses (100 and 500 µg) are consecutively administered to 10 patients with T1D in two different settings: low and high-carb diets (total of 20 datasets). The model performance is compared to three other EGP models from literature under different identification criteria. The receptors model achieved the lowest root mean squared error regardless of the diet and the individualization method.
Original language | English |
---|---|
Book series | IFAC-PapersOnLine |
Volume | 56 |
Issue number | 2 |
Pages (from-to) | 9666-9671 |
DOIs | |
Publication status | Published - 2023 |
Event | 22nd IFAC World Congress - Pacific Convention Plaza Yokohama, Yokohama, Japan Duration: 9 Jul 2023 → 14 Jul 2023 Conference number: 22 |
Conference
Conference | 22nd IFAC World Congress |
---|---|
Number | 22 |
Location | Pacific Convention Plaza Yokohama |
Country/Territory | Japan |
City | Yokohama |
Period | 09/07/2023 → 14/07/2023 |
Sponsor | Azbil Corporation, Fujita Corporation, Hitachi, Ltd., Kumagai Gumi Co., Ltd., The Society of Instrument and Control Engineers (SICE) |
Keywords
- Artificial Pancreas
- Biomedical system modeling
- Diabetes
- Identification and validation
- Nonlinear system identification
- Physiological Model